Filing Flows › Onconetix (ONCO) › Q2 2026 › vs Q1 2026
Onconetix (ONCO) Q2 2026 vs Q1 2026 (quarter over quarter)
Onconetix's revenue fell $4K (-20%) from $21K in Q1 2026 to $17K in Q2 2026.
Onconetix, Q2 2026: revenue $17K (-84% year over year), net loss $2.9M, operating cash flow −$1.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $17K | $21K | −$4K | -20% |
| Net loss | $2.9M | $4.2M | −$1.3M | -32% |
| Costs & expenses | $2.9M | $10.2M | −$7.4M | -72% |
| Operating costs | $2.7M | $10.2M | −$7.5M | -73% |
| Interest & other, net | $137K | −$6.0M | $6.1M | — |
| Cost of revenue | $13K | $23K | −$10K | -45% |
| SG&A | $2.2M | $2.0M | $206K | +10% |
| Other operating costs | $489K | $8.2M | −$7.7M | -94% |
| Operating cash sources | $2.9M | $4.2M | −$1.3M | -32% |
| Depreciation & amortization | $3K | $5K | −$3K | -51% |
| Share-based compensation | $7K | $22K | −$15K | -67% |
| Working capital & other | $939K | $2.1M | −$1.1M | -55% |
| Cash used in operations | $1.9M | $2.1M | −$203K | -10% |
| Net loss absorbed | $2.9M | $4.2M | −$1.3M | -32% |
Questions
How much did Onconetix's revenue grow quarter over quarter in Q2 2026?
Onconetix's revenue fell $4K (-20%) from $21K in Q1 2026 to $17K in Q2 2026.